Evidence map›Paper›PMID 42215453›Full record

SynthesisTranslational psychiatry2026

Emotion regulation impairment across psychiatric disorders: a systematic review and meta-analysis.

Matthew E Sloan, Jordan Stellern, Ke Bin Xiao, Alisa Germeyer, Kevin Gill, Viyaleta Laputsina, Benoit H Mulsant, Anthony Ngoy, Martin Nguyen, Victor M Tang and 2 more

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Matthew E SloanAddictions Division, Centre for Addiction and Mental Health, Toronto, ON, Canada. matthew.sloan@camh.ca.ORCID http://orcid.org/0000-0003-2172-8802
Jordan StellernUniversity of Colorado Anschutz Medical Campus, Department of Radiology, Aurora, CO, USA.
Ke Bin XiaoAddictions Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Alisa GermeyerCollege of Osteopathic Medicine, Rocky Vista University, Colorado Campus, Englewood, CO, USA.
Kevin GillKeck School of Medicine, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0009-0004-2477-2846
Viyaleta LaputsinaCollege of Osteopathic Medicine, Rocky Vista University, Colorado Campus, Englewood, CO, USA.
Benoit H MulsantDepartment of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-0303-6450
Anthony NgoyAddictions Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Martin NguyenAddictions Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Victor M TangAddictions Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Marcos SanchesBiostatistics Core, Centre for Addiction and Mental Health, Toronto, ON, Canada.ORCID http://orcid.org/0000-0001-9075-1761
Joshua L GowinUniversity of Colorado Anschutz Medical Campus, Department of Radiology, Aurora, CO, USA. joshua.gowin@cuanschutz.edu.ORCID http://orcid.org/0000-0002-9016-6973

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psychiatric disorders are among the leading contributors to the global burden of disease. Impaired emotion regulation has been hypothesized to be a transdiagnostic feature of psychiatric disorders, but this has not been proven across all classes of psychopathology. We sought to systematically review and meta-analyze emotion regulation impairment across major psychiatric disorders to determine if impairment is truly transdiagnostic. Selected studies compared healthy controls and individuals with a psychiatric disorder. Emotion regulation was assessed by the Difficulties in Emotion Regulation Scale (DERS), the Emotion Regulation Questionnaire (ERQ), and two other scales. Differences between cases and controls were estimated using Hedges' g for each disorder and scale. 188 studies were included, representing 563 case-control comparisons across 15 diagnoses with 11,201 cases and 9609 controls. For the DERS, case-control differences were large and significant for all 12 disorders analyzed, with effect sizes ranging from 0.94 (95% CI: 0.67-1.21) for bipolar disorder to 2.55 (95% CI: 2.28-2.83) for borderline personality disorder (BPD); BPD had a significantly larger case-control effect size than most other disorders. For the ERQ, use of cognitive reappraisal (an adaptive form of emotion regulation) was reduced in all disorders except panic disorder and use of expressive suppression (a maladaptive form of emotion regulation) was greater in all disorders except ADHD and OCD. Overall, individuals with major psychiatric disorders demonstrated reduced capacity to regulate their emotions across diagnoses and measures, suggesting that interventions which improve emotion regulation could be beneficial to prevent or treat many psychiatric disorders.

Indexed as

Emotional RegulationMental DisordersHumans

Identifiers

PMID42215453
PMCPMC13424126

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.